• Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    Belgium Germany Romania Spain
  • Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

    Recruiting

    4 1 1
    France
  • Study of IMC-M113V for Patients with Chronic HIV Infection Who Are Virologically Suppressed

    Recruiting

    2 1 1
    Investigated diseases:
    Belgium Spain
  • Study of ADS-010 for Adults with Facioscapulohumeral Muscular Dystrophy Type 1

    Recruiting

    2 1 1
    Investigated drugs:
    Germany Italy The Netherlands Spain
  • Study on the Effect of Levobupivacaine in Reducing Chronic Pain After Open Inguinal Hernia Repair in Patients

    Recruiting

    3 1 1 1
    Spain
  • Study on Leflunomide for Preventing Relapses in Patients with Polymyalgia Rheumatica During Steroid Reduction

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of Nivolumab and Nivolumab Plus Relatlimab for Patients with Advanced or Metastatic Skin Squamous Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

    Recruiting

    3 1 1
    Investigated diseases:
    Belgium France Germany Hungary Italy Poland +1
  • Study of Pembrolizumab and MK-2870 for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Czechia France Germany Hungary Ireland +4

powered by